Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06563414 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 2, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Jul 2025 to Dec 2025v4
  2. Enrollment target: 15 to 40
    • Primary and study completion dates: Jan 2025 to Jul 2025
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description shortened, about 40 words
    v3
  3. Secondary endpoint revisedv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a non-interventional, observational study that will evaluate the natural history of corneal abrasions in patients with Dystrophic Epidermolysis Bullosa (DEB).
Trial Details
NCT Number NCT06563414
Lead Sponsor Krystal Biotech, Inc.
Conditions
(from sponsor)		 Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa Dystrophica, Recessive, Epidermolysis Bullosa Dystrophica Dominans
Related terms Corneal Injuries, Epidermolysis Bullosa Dystrophica
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov